aluates Reports

$ 0.0

Global Pediatric Anti-Flu Drugs Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-35E18185

Pediatric Anti Flu Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

BUY CHAPTERS

Global Pediatric Anti-Flu Drugs Market Insights, Forecast to 2030

Code: QYRE-Auto-35E18185

Report

December 2024

Pages:97

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

Johnson & Johnson

GlaxoSmithKline(GSK )

Rostec

Cipla Ltd

Pediatric Anti-Flu Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Pediatric Anti-Flu Drugs Market

The global Pediatric Anti-Flu Drugs market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Pediatric Anti-Flu Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Pediatric Anti-Flu Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Pediatric Anti-Flu Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pediatric Anti-Flu Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pediatric Anti-Flu Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Pediatric Anti-Flu Drugs sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Pediatric Anti-Flu Drugs Market Report

Report Metric	Details
Report Name	Pediatric Anti-Flu Drugs Market
CAGR	5%
Segment by Type	Oseltamivir Zanamivir
Segment by Application	Hospital Clinic Online Sales Others
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GlaxoSmithKline (GSK), Rostec, Cipla
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Pediatric Anti-Flu Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Pediatric Anti-Flu Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pediatric Anti-Flu Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pediatric Anti-Flu Drugs Market report?

Ans: The main players in the Pediatric Anti-Flu Drugs Market are GlaxoSmithKline (GSK), Rostec, Cipla

What are the Application segmentation covered in the Pediatric Anti-Flu Drugs Market report?

Ans: The Applications covered in the Pediatric Anti-Flu Drugs Market report are Hospital, Clinic, Online Sales, Others

What are the Type segmentation covered in the Pediatric Anti-Flu Drugs Market report?

Ans: The Types covered in the Pediatric Anti-Flu Drugs Market report are Oseltamivir, Zanamivir

1 Study Coverage

1.1 Pediatric Anti-Flu Drugs Product Introduction

1.2 Market by Type

1.2.1 Global Pediatric Anti-Flu Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Oseltamivir

1.2.3 Zanamivir

1.3 Market by Application

1.3.1 Global Pediatric Anti-Flu Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Online Sales

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Pediatric Anti-Flu Drugs Sales Estimates and Forecasts 2019-2030

2.2 Global Pediatric Anti-Flu Drugs Revenue by Region

2.2.1 Global Pediatric Anti-Flu Drugs Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Pediatric Anti-Flu Drugs Revenue by Region (2019-2024)

2.2.3 Global Pediatric Anti-Flu Drugs Revenue by Region (2025-2030)

2.2.4 Global Pediatric Anti-Flu Drugs Revenue Market Share by Region (2019-2030)

2.3 Global Pediatric Anti-Flu Drugs Sales Estimates and Forecasts 2019-2030

2.4 Global Pediatric Anti-Flu Drugs Sales by Region

2.4.1 Global Pediatric Anti-Flu Drugs Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Pediatric Anti-Flu Drugs Sales by Region (2019-2024)

2.4.3 Global Pediatric Anti-Flu Drugs Sales by Region (2025-2030)

2.4.4 Global Pediatric Anti-Flu Drugs Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Pediatric Anti-Flu Drugs Sales by Manufacturers

3.1.1 Global Pediatric Anti-Flu Drugs Sales by Manufacturers (2019-2024)

3.1.2 Global Pediatric Anti-Flu Drugs Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pediatric Anti-Flu Drugs in 2023

3.2 Global Pediatric Anti-Flu Drugs Revenue by Manufacturers

3.2.1 Global Pediatric Anti-Flu Drugs Revenue by Manufacturers (2019-2024)

3.2.2 Global Pediatric Anti-Flu Drugs Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Pediatric Anti-Flu Drugs Revenue in 2023

3.3 Global Key Players of Pediatric Anti-Flu Drugs, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Pediatric Anti-Flu Drugs Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Pediatric Anti-Flu Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Pediatric Anti-Flu Drugs, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Pediatric Anti-Flu Drugs, Product Offered and Application

3.8 Global Key Manufacturers of Pediatric Anti-Flu Drugs, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Pediatric Anti-Flu Drugs Sales by Type

4.1.1 Global Pediatric Anti-Flu Drugs Historical Sales by Type (2019-2024)

4.1.2 Global Pediatric Anti-Flu Drugs Forecasted Sales by Type (2025-2030)

4.1.3 Global Pediatric Anti-Flu Drugs Sales Market Share by Type (2019-2030)

4.2 Global Pediatric Anti-Flu Drugs Revenue by Type

4.2.1 Global Pediatric Anti-Flu Drugs Historical Revenue by Type (2019-2024)

4.2.2 Global Pediatric Anti-Flu Drugs Forecasted Revenue by Type (2025-2030)

4.2.3 Global Pediatric Anti-Flu Drugs Revenue Market Share by Type (2019-2030)

4.3 Global Pediatric Anti-Flu Drugs Price by Type

4.3.1 Global Pediatric Anti-Flu Drugs Price by Type (2019-2024)

4.3.2 Global Pediatric Anti-Flu Drugs Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Pediatric Anti-Flu Drugs Sales by Application

5.1.1 Global Pediatric Anti-Flu Drugs Historical Sales by Application (2019-2024)

5.1.2 Global Pediatric Anti-Flu Drugs Forecasted Sales by Application (2025-2030)

5.1.3 Global Pediatric Anti-Flu Drugs Sales Market Share by Application (2019-2030)

5.2 Global Pediatric Anti-Flu Drugs Revenue by Application

5.2.1 Global Pediatric Anti-Flu Drugs Historical Revenue by Application (2019-2024)

5.2.2 Global Pediatric Anti-Flu Drugs Forecasted Revenue by Application (2025-2030)

5.2.3 Global Pediatric Anti-Flu Drugs Revenue Market Share by Application (2019-2030)

5.3 Global Pediatric Anti-Flu Drugs Price by Application

5.3.1 Global Pediatric Anti-Flu Drugs Price by Application (2019-2024)

5.3.2 Global Pediatric Anti-Flu Drugs Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Pediatric Anti-Flu Drugs Market Size by Type

6.1.1 US & Canada Pediatric Anti-Flu Drugs Sales by Type (2019-2030)

6.1.2 US & Canada Pediatric Anti-Flu Drugs Revenue by Type (2019-2030)

6.2 US & Canada Pediatric Anti-Flu Drugs Market Size by Application

6.2.1 US & Canada Pediatric Anti-Flu Drugs Sales by Application (2019-2030)

6.2.2 US & Canada Pediatric Anti-Flu Drugs Revenue by Application (2019-2030)

6.3 US & Canada Pediatric Anti-Flu Drugs Market Size by Country

6.3.1 US & Canada Pediatric Anti-Flu Drugs Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Pediatric Anti-Flu Drugs Sales by Country (2019-2030)

6.3.3 US & Canada Pediatric Anti-Flu Drugs Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Pediatric Anti-Flu Drugs Market Size by Type

7.1.1 Europe Pediatric Anti-Flu Drugs Sales by Type (2019-2030)

7.1.2 Europe Pediatric Anti-Flu Drugs Revenue by Type (2019-2030)

7.2 Europe Pediatric Anti-Flu Drugs Market Size by Application

7.2.1 Europe Pediatric Anti-Flu Drugs Sales by Application (2019-2030)

7.2.2 Europe Pediatric Anti-Flu Drugs Revenue by Application (2019-2030)

7.3 Europe Pediatric Anti-Flu Drugs Market Size by Country

7.3.1 Europe Pediatric Anti-Flu Drugs Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Pediatric Anti-Flu Drugs Sales by Country (2019-2030)

7.3.3 Europe Pediatric Anti-Flu Drugs Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Pediatric Anti-Flu Drugs Market Size

8.1.1 China Pediatric Anti-Flu Drugs Sales (2019-2030)

8.1.2 China Pediatric Anti-Flu Drugs Revenue (2019-2030)

8.2 China Pediatric Anti-Flu Drugs Market Size by Application

8.2.1 China Pediatric Anti-Flu Drugs Sales by Application (2019-2030)

8.2.2 China Pediatric Anti-Flu Drugs Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Pediatric Anti-Flu Drugs Market Size by Type

9.1.1 Asia Pediatric Anti-Flu Drugs Sales by Type (2019-2030)

9.1.2 Asia Pediatric Anti-Flu Drugs Revenue by Type (2019-2030)

9.2 Asia Pediatric Anti-Flu Drugs Market Size by Application

9.2.1 Asia Pediatric Anti-Flu Drugs Sales by Application (2019-2030)

9.2.2 Asia Pediatric Anti-Flu Drugs Revenue by Application (2019-2030)

9.3 Asia Pediatric Anti-Flu Drugs Sales by Region

9.3.1 Asia Pediatric Anti-Flu Drugs Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Pediatric Anti-Flu Drugs Revenue by Region (2019-2030)

9.3.3 Asia Pediatric Anti-Flu Drugs Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Pediatric Anti-Flu Drugs Market Size by Type

10.1.1 Middle East, Africa and Latin America Pediatric Anti-Flu Drugs Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Pediatric Anti-Flu Drugs Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Pediatric Anti-Flu Drugs Market Size by Application

10.2.1 Middle East, Africa and Latin America Pediatric Anti-Flu Drugs Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Pediatric Anti-Flu Drugs Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Pediatric Anti-Flu Drugs Sales by Country

10.3.1 Middle East, Africa and Latin America Pediatric Anti-Flu Drugs Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Pediatric Anti-Flu Drugs Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Pediatric Anti-Flu Drugs Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Roche

11.1.1 Roche Company Information

11.1.2 Roche Overview

11.1.3 Roche Pediatric Anti-Flu Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Roche Pediatric Anti-Flu Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Roche Recent Developments

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Information

11.2.2 Johnson & Johnson Overview

11.2.3 Johnson & Johnson Pediatric Anti-Flu Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Johnson & Johnson Pediatric Anti-Flu Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Johnson & Johnson Recent Developments

11.3 GlaxoSmithKline (GSK)

11.3.1 GlaxoSmithKline (GSK) Company Information

11.3.2 GlaxoSmithKline (GSK) Overview

11.3.3 GlaxoSmithKline (GSK) Pediatric Anti-Flu Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 GlaxoSmithKline (GSK) Pediatric Anti-Flu Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 GlaxoSmithKline (GSK) Recent Developments

11.4 Rostec

11.4.1 Rostec Company Information

11.4.2 Rostec Overview

11.4.3 Rostec Pediatric Anti-Flu Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Rostec Pediatric Anti-Flu Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Rostec Recent Developments

11.5 Cipla

11.5.1 Cipla Company Information

11.5.2 Cipla Overview

11.5.3 Cipla Pediatric Anti-Flu Drugs Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Cipla Pediatric Anti-Flu Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Cipla Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Pediatric Anti-Flu Drugs Industry Chain Analysis

12.2 Pediatric Anti-Flu Drugs Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Pediatric Anti-Flu Drugs Production Mode & Process

12.4 Pediatric Anti-Flu Drugs Sales and Marketing

12.4.1 Pediatric Anti-Flu Drugs Sales Channels

12.4.2 Pediatric Anti-Flu Drugs Distributors

12.5 Pediatric Anti-Flu Drugs Customers

13 Market Dynamics

13.1 Pediatric Anti-Flu Drugs Industry Trends

13.2 Pediatric Anti-Flu Drugs Market Drivers

13.3 Pediatric Anti-Flu Drugs Market Challenges

13.4 Pediatric Anti-Flu Drugs Market Restraints

14 Key Findings in The Global Pediatric Anti-Flu Drugs Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Roche

Johnson & Johnson

GlaxoSmithKline(GSK )

Rostec

Cipla Ltd

List of Tables

Table 1. Global Pediatric Anti-Flu Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Oseltamivir

Table 3. Major Manufacturers of Zanamivir

Table 4. Global Pediatric Anti-Flu Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 5. Global Pediatric Anti-Flu Drugs Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Pediatric Anti-Flu Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 7. Global Pediatric Anti-Flu Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 8. Global Pediatric Anti-Flu Drugs Revenue Market Share by Region (2019-2024)

Table 9. Global Pediatric Anti-Flu Drugs Revenue Market Share by Region (2025-2030)

Table 10. Global Pediatric Anti-Flu Drugs Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 11. Global Pediatric Anti-Flu Drugs Sales by Region (2019-2024) & (K Units)

Table 12. Global Pediatric Anti-Flu Drugs Sales by Region (2025-2030) & (K Units)

Table 13. Global Pediatric Anti-Flu Drugs Sales Market Share by Region (2019-2024)

Table 14. Global Pediatric Anti-Flu Drugs Sales Market Share by Region (2025-2030)

Table 15. Global Pediatric Anti-Flu Drugs Sales by Manufacturers (2019-2024) & (K Units)

Table 16. Global Pediatric Anti-Flu Drugs Sales Share by Manufacturers (2019-2024)

Table 17. Global Pediatric Anti-Flu Drugs Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 18. Global Pediatric Anti-Flu Drugs Revenue Share by Manufacturers (2019-2024)

Table 19. Global Key Players of Pediatric Anti-Flu Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 20. Pediatric Anti-Flu Drugs Price by Manufacturers 2019-2024 (US$/Unit)

Table 21. Global Pediatric Anti-Flu Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Pediatric Anti-Flu Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Anti-Flu Drugs as of 2023)

Table 23. Global Key Manufacturers of Pediatric Anti-Flu Drugs, Manufacturing Base Distribution and Headquarters

Table 24. Global Key Manufacturers of Pediatric Anti-Flu Drugs, Product Offered and Application

Table 25. Global Key Manufacturers of Pediatric Anti-Flu Drugs, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Pediatric Anti-Flu Drugs Sales by Type (2019-2024) & (K Units)

Table 28. Global Pediatric Anti-Flu Drugs Sales by Type (2025-2030) & (K Units)

Table 29. Global Pediatric Anti-Flu Drugs Sales Share by Type (2019-2024)

Table 30. Global Pediatric Anti-Flu Drugs Sales Share by Type (2025-2030)

Table 31. Global Pediatric Anti-Flu Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 32. Global Pediatric Anti-Flu Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 33. Global Pediatric Anti-Flu Drugs Revenue Share by Type (2019-2024)

Table 34. Global Pediatric Anti-Flu Drugs Revenue Share by Type (2025-2030)

Table 35. Pediatric Anti-Flu Drugs Price by Type (2019-2024) & (US$/Unit)

Table 36. Global Pediatric Anti-Flu Drugs Price Forecast by Type (2025-2030) & (US$/Unit)

Table 37. Global Pediatric Anti-Flu Drugs Sales by Application (2019-2024) & (K Units)

Table 38. Global Pediatric Anti-Flu Drugs Sales by Application (2025-2030) & (K Units)

Table 39. Global Pediatric Anti-Flu Drugs Sales Share by Application (2019-2024)

Table 40. Global Pediatric Anti-Flu Drugs Sales Share by Application (2025-2030)

Table 41. Global Pediatric Anti-Flu Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 42. Global Pediatric Anti-Flu Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 43. Global Pediatric Anti-Flu Drugs Revenue Share by Application (2019-2024)

Table 44. Global Pediatric Anti-Flu Drugs Revenue Share by Application (2025-2030)

Table 45. Pediatric Anti-Flu Drugs Price by Application (2019-2024) & (US$/Unit)

Table 46. Global Pediatric Anti-Flu Drugs Price Forecast by Application (2025-2030) & (US$/Unit)

Table 47. US & Canada Pediatric Anti-Flu Drugs Sales by Type (2019-2024) & (K Units)

Table 48. US & Canada Pediatric Anti-Flu Drugs Sales by Type (2025-2030) & (K Units)

Table 49. US & Canada Pediatric Anti-Flu Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 50. US & Canada Pediatric Anti-Flu Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 51. US & Canada Pediatric Anti-Flu Drugs Sales by Application (2019-2024) & (K Units)

Table 52. US & Canada Pediatric Anti-Flu Drugs Sales by Application (2025-2030) & (K Units)

Table 53. US & Canada Pediatric Anti-Flu Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 54. US & Canada Pediatric Anti-Flu Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 55. US & Canada Pediatric Anti-Flu Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 56. US & Canada Pediatric Anti-Flu Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 57. US & Canada Pediatric Anti-Flu Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 58. US & Canada Pediatric Anti-Flu Drugs Sales by Country (2019-2024) & (K Units)

Table 59. US & Canada Pediatric Anti-Flu Drugs Sales by Country (2025-2030) & (K Units)

Table 60. Europe Pediatric Anti-Flu Drugs Sales by Type (2019-2024) & (K Units)

Table 61. Europe Pediatric Anti-Flu Drugs Sales by Type (2025-2030) & (K Units)

Table 62. Europe Pediatric Anti-Flu Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 63. Europe Pediatric Anti-Flu Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 64. Europe Pediatric Anti-Flu Drugs Sales by Application (2019-2024) & (K Units)

Table 65. Europe Pediatric Anti-Flu Drugs Sales by Application (2025-2030) & (K Units)

Table 66. Europe Pediatric Anti-Flu Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 67. Europe Pediatric Anti-Flu Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 68. Europe Pediatric Anti-Flu Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 69. Europe Pediatric Anti-Flu Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 70. Europe Pediatric Anti-Flu Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 71. Europe Pediatric Anti-Flu Drugs Sales by Country (2019-2024) & (K Units)

Table 72. Europe Pediatric Anti-Flu Drugs Sales by Country (2025-2030) & (K Units)

Table 73. China Pediatric Anti-Flu Drugs Sales by Type (2019-2024) & (K Units)

Table 74. China Pediatric Anti-Flu Drugs Sales by Type (2025-2030) & (K Units)

Table 75. China Pediatric Anti-Flu Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 76. China Pediatric Anti-Flu Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 77. China Pediatric Anti-Flu Drugs Sales by Application (2019-2024) & (K Units)

Table 78. China Pediatric Anti-Flu Drugs Sales by Application (2025-2030) & (K Units)

Table 79. China Pediatric Anti-Flu Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 80. China Pediatric Anti-Flu Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 81. Asia Pediatric Anti-Flu Drugs Sales by Type (2019-2024) & (K Units)

Table 82. Asia Pediatric Anti-Flu Drugs Sales by Type (2025-2030) & (K Units)

Table 83. Asia Pediatric Anti-Flu Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 84. Asia Pediatric Anti-Flu Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 85. Asia Pediatric Anti-Flu Drugs Sales by Application (2019-2024) & (K Units)

Table 86. Asia Pediatric Anti-Flu Drugs Sales by Application (2025-2030) & (K Units)

Table 87. Asia Pediatric Anti-Flu Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 88. Asia Pediatric Anti-Flu Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 89. Asia Pediatric Anti-Flu Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 90. Asia Pediatric Anti-Flu Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 91. Asia Pediatric Anti-Flu Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 92. Asia Pediatric Anti-Flu Drugs Sales by Region (2019-2024) & (K Units)

Table 93. Asia Pediatric Anti-Flu Drugs Sales by Region (2025-2030) & (K Units)

Table 94. Middle East, Africa and Latin America Pediatric Anti-Flu Drugs Sales by Type (2019-2024) & (K Units)

Table 95. Middle East, Africa and Latin America Pediatric Anti-Flu Drugs Sales by Type (2025-2030) & (K Units)

Table 96. Middle East, Africa and Latin America Pediatric Anti-Flu Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 97. Middle East, Africa and Latin America Pediatric Anti-Flu Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 98. Middle East, Africa and Latin America Pediatric Anti-Flu Drugs Sales by Application (2019-2024) & (K Units)

Table 99. Middle East, Africa and Latin America Pediatric Anti-Flu Drugs Sales by Application (2025-2030) & (K Units)

Table 100. Middle East, Africa and Latin America Pediatric Anti-Flu Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 101. Middle East, Africa and Latin America Pediatric Anti-Flu Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 102. Middle East, Africa and Latin America Pediatric Anti-Flu Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 103. Middle East, Africa and Latin America Pediatric Anti-Flu Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Pediatric Anti-Flu Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Pediatric Anti-Flu Drugs Sales by Country (2019-2024) & (K Units)

Table 106. Middle East, Africa and Latin America Pediatric Anti-Flu Drugs Sales by Country (2025-2030) & (K Units)

Table 107. Roche Company Information

Table 108. Roche Description and Major Businesses

Table 109. Roche Pediatric Anti-Flu Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. Roche Pediatric Anti-Flu Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. Roche Recent Developments

Table 112. Johnson & Johnson Company Information

Table 113. Johnson & Johnson Description and Major Businesses

Table 114. Johnson & Johnson Pediatric Anti-Flu Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. Johnson & Johnson Pediatric Anti-Flu Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. Johnson & Johnson Recent Developments

Table 117. GlaxoSmithKline (GSK) Company Information

Table 118. GlaxoSmithKline (GSK) Description and Major Businesses

Table 119. GlaxoSmithKline (GSK) Pediatric Anti-Flu Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 120. GlaxoSmithKline (GSK) Pediatric Anti-Flu Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. GlaxoSmithKline (GSK) Recent Developments

Table 122. Rostec Company Information

Table 123. Rostec Description and Major Businesses

Table 124. Rostec Pediatric Anti-Flu Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 125. Rostec Pediatric Anti-Flu Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Rostec Recent Developments

Table 127. Cipla Company Information

Table 128. Cipla Description and Major Businesses

Table 129. Cipla Pediatric Anti-Flu Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 130. Cipla Pediatric Anti-Flu Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. Cipla Recent Developments

Table 132. Key Raw Materials Lists

Table 133. Raw Materials Key Suppliers Lists

Table 134. Pediatric Anti-Flu Drugs Distributors List

Table 135. Pediatric Anti-Flu Drugs Customers List

Table 136. Pediatric Anti-Flu Drugs Market Trends

Table 137. Pediatric Anti-Flu Drugs Market Drivers

Table 138. Pediatric Anti-Flu Drugs Market Challenges

Table 139. Pediatric Anti-Flu Drugs Market Restraints

Table 140. Research Programs/Design for This Report

Table 141. Key Data Information from Secondary Sources

Table 142. Key Data Information from Primary Sources

List of Figures

Figure 1. Pediatric Anti-Flu Drugs Product Picture

Figure 2. Global Pediatric Anti-Flu Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Pediatric Anti-Flu Drugs Market Share by Type in 2023 & 2030

Figure 4. Oseltamivir Product Picture

Figure 5. Zanamivir Product Picture

Figure 6. Global Pediatric Anti-Flu Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Pediatric Anti-Flu Drugs Market Share by Application in 2023 & 2030

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Online Sales

Figure 11. Others

Figure 12. Pediatric Anti-Flu Drugs Report Years Considered

Figure 13. Global Pediatric Anti-Flu Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Pediatric Anti-Flu Drugs Revenue 2019-2030 (US$ Million)

Figure 15. Global Pediatric Anti-Flu Drugs Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 16. Global Pediatric Anti-Flu Drugs Revenue Market Share by Region (2019-2030)

Figure 17. Global Pediatric Anti-Flu Drugs Sales 2019-2030 ((K Units)

Figure 18. Global Pediatric Anti-Flu Drugs Sales Market Share by Region (2019-2030)

Figure 19. US & Canada Pediatric Anti-Flu Drugs Sales YoY (2019-2030) & (K Units)

Figure 20. US & Canada Pediatric Anti-Flu Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 21. Europe Pediatric Anti-Flu Drugs Sales YoY (2019-2030) & (K Units)

Figure 22. Europe Pediatric Anti-Flu Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 23. China Pediatric Anti-Flu Drugs Sales YoY (2019-2030) & (K Units)

Figure 24. China Pediatric Anti-Flu Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 25. Asia (excluding China) Pediatric Anti-Flu Drugs Sales YoY (2019-2030) & (K Units)

Figure 26. Asia (excluding China) Pediatric Anti-Flu Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 27. Middle East, Africa and Latin America Pediatric Anti-Flu Drugs Sales YoY (2019-2030) & (K Units)

Figure 28. Middle East, Africa and Latin America Pediatric Anti-Flu Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 29. The Pediatric Anti-Flu Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 30. The Top 5 and 10 Largest Manufacturers of Pediatric Anti-Flu Drugs in the World: Market Share by Pediatric Anti-Flu Drugs Revenue in 2023

Figure 31. Global Pediatric Anti-Flu Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 32. Global Pediatric Anti-Flu Drugs Sales Market Share by Type (2019-2030)

Figure 33. Global Pediatric Anti-Flu Drugs Revenue Market Share by Type (2019-2030)

Figure 34. Global Pediatric Anti-Flu Drugs Sales Market Share by Application (2019-2030)

Figure 35. Global Pediatric Anti-Flu Drugs Revenue Market Share by Application (2019-2030)

Figure 36. US & Canada Pediatric Anti-Flu Drugs Sales Market Share by Type (2019-2030)

Figure 37. US & Canada Pediatric Anti-Flu Drugs Revenue Market Share by Type (2019-2030)

Figure 38. US & Canada Pediatric Anti-Flu Drugs Sales Market Share by Application (2019-2030)

Figure 39. US & Canada Pediatric Anti-Flu Drugs Revenue Market Share by Application (2019-2030)

Figure 40. US & Canada Pediatric Anti-Flu Drugs Revenue Share by Country (2019-2030)

Figure 41. US & Canada Pediatric Anti-Flu Drugs Sales Share by Country (2019-2030)

Figure 42. U.S. Pediatric Anti-Flu Drugs Revenue (2019-2030) & (US$ Million)

Figure 43. Canada Pediatric Anti-Flu Drugs Revenue (2019-2030) & (US$ Million)

Figure 44. Europe Pediatric Anti-Flu Drugs Sales Market Share by Type (2019-2030)

Figure 45. Europe Pediatric Anti-Flu Drugs Revenue Market Share by Type (2019-2030)

Figure 46. Europe Pediatric Anti-Flu Drugs Sales Market Share by Application (2019-2030)

Figure 47. Europe Pediatric Anti-Flu Drugs Revenue Market Share by Application (2019-2030)

Figure 48. Europe Pediatric Anti-Flu Drugs Revenue Share by Country (2019-2030)

Figure 49. Europe Pediatric Anti-Flu Drugs Sales Share by Country (2019-2030)

Figure 50. Germany Pediatric Anti-Flu Drugs Revenue (2019-2030) & (US$ Million)

Figure 51. France Pediatric Anti-Flu Drugs Revenue (2019-2030) & (US$ Million)

Figure 52. U.K. Pediatric Anti-Flu Drugs Revenue (2019-2030) & (US$ Million)

Figure 53. Italy Pediatric Anti-Flu Drugs Revenue (2019-2030) & (US$ Million)

Figure 54. Russia Pediatric Anti-Flu Drugs Revenue (2019-2030) & (US$ Million)

Figure 55. China Pediatric Anti-Flu Drugs Sales Market Share by Type (2019-2030)

Figure 56. China Pediatric Anti-Flu Drugs Revenue Market Share by Type (2019-2030)

Figure 57. China Pediatric Anti-Flu Drugs Sales Market Share by Application (2019-2030)

Figure 58. China Pediatric Anti-Flu Drugs Revenue Market Share by Application (2019-2030)

Figure 59. Asia Pediatric Anti-Flu Drugs Sales Market Share by Type (2019-2030)

Figure 60. Asia Pediatric Anti-Flu Drugs Revenue Market Share by Type (2019-2030)

Figure 61. Asia Pediatric Anti-Flu Drugs Sales Market Share by Application (2019-2030)

Figure 62. Asia Pediatric Anti-Flu Drugs Revenue Market Share by Application (2019-2030)

Figure 63. Asia Pediatric Anti-Flu Drugs Revenue Share by Region (2019-2030)

Figure 64. Asia Pediatric Anti-Flu Drugs Sales Share by Region (2019-2030)

Figure 65. Japan Pediatric Anti-Flu Drugs Revenue (2019-2030) & (US$ Million)

Figure 66. South Korea Pediatric Anti-Flu Drugs Revenue (2019-2030) & (US$ Million)

Figure 67. China Taiwan Pediatric Anti-Flu Drugs Revenue (2019-2030) & (US$ Million)

Figure 68. Southeast Asia Pediatric Anti-Flu Drugs Revenue (2019-2030) & (US$ Million)

Figure 69. India Pediatric Anti-Flu Drugs Revenue (2019-2030) & (US$ Million)

Figure 70. Middle East, Africa and Latin America Pediatric Anti-Flu Drugs Sales Market Share by Type (2019-2030)

Figure 71. Middle East, Africa and Latin America Pediatric Anti-Flu Drugs Revenue Market Share by Type (2019-2030)

Figure 72. Middle East, Africa and Latin America Pediatric Anti-Flu Drugs Sales Market Share by Application (2019-2030)

Figure 73. Middle East, Africa and Latin America Pediatric Anti-Flu Drugs Revenue Market Share by Application (2019-2030)

Figure 74. Middle East, Africa and Latin America Pediatric Anti-Flu Drugs Revenue Share by Country (2019-2030)

Figure 75. Middle East, Africa and Latin America Pediatric Anti-Flu Drugs Sales Share by Country (2019-2030)

Figure 76. Brazil Pediatric Anti-Flu Drugs Revenue (2019-2030) & (US$ Million)

Figure 77. Mexico Pediatric Anti-Flu Drugs Revenue (2019-2030) & (US$ Million)

Figure 78. Turkey Pediatric Anti-Flu Drugs Revenue (2019-2030) & (US$ Million)

Figure 79. Israel Pediatric Anti-Flu Drugs Revenue (2019-2030) & (US$ Million)

Figure 80. GCC Countries Pediatric Anti-Flu Drugs Revenue (2019-2030) & (US$ Million)

Figure 81. Pediatric Anti-Flu Drugs Value Chain

Figure 82. Pediatric Anti-Flu Drugs Production Process

Figure 83. Channels of Distribution

Figure 84. Distributors Profiles

Figure 85. Bottom-up and Top-down Approaches for This Report

Figure 86. Data Triangulation

Figure 87. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions